Trinity Biotech falls below Nasdaq public float requirement
Source: SeekingAlpha
2026-02-20 17:13:25 ET
More on Trinity Biotech
- Trinity Biotech rises on order for 9M TrinScreen HIV tests
- Seeking Alpha’s Quant Rating on Trinity Biotech
- Financial information for Trinity Biotech
Read the full article on Seeking Alpha
For further details see:
Trinity Biotech falls below Nasdaq public float requirement
Trinity Biotech plc
NASDAQ: TRIB
TRIB Trading
1.01% G/L:
$0.603 Last:
48,119 Volume:
$0.606 Open:
TRIB Latest News
March 23, 2026 09:23:07 am
Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture(TM) Prostate Cancer Test
March 18, 2026 08:30:00 am
Trinity Biotech Announces Collaboration with University at Buffalo to Commercialize Novel Biomarkers for Sjögren's Syndrome
TRIB Stock Data
$17,567,131
17,007,692
5.8%
31
N/A
Medical Diagnostics & Screening
Healthcare
IE
Bray
